Please login to the form below

Not currently logged in
Email:
Password:

Abbott launches Bluetooth cardiac monitor Confirm RX in the US

The device sits under the patient’s skin and connects to the firm's myMerlin app

heart

Abbott has launched a cardiac monitor in the US that communicates with a patient’s smartphone using Bluetooth wireless technology.

The Confirm RX sits under the patient’s skin and connects to the myMerlin app, which can then be accessed by physicians to identify and diagnose cardiac arrhythmias.

Its approval by the US Food and Drug Administration (FDA) and subsequent launch is a big win for the Chicago healthcare group, as the device is the first and only smartphone compatible ICM in the US.

Avi Fischer, divisional vice president and medical director, cardiac rhythm management business, Abbott, said: “Confirm RX shows what we can do with cutting edge communication technology and the most advanced medical devices that provide new opportunities to improve patient care.

“By offering a device that uses Bluetooth wireless technology from the patient’s smartphone, we can help physicians easily and remotely diagnosed potentially dangerous abnormal heart beats without requiring the patient to use a separate or cumbersome recording device.”

Arrhythmia can develop when a disease or injury disrupts the heart’s electrical signals causing the heart to beat erratically, which can change a patient’s blood flow and cause palpitations, dizziness, shortness of breath of fainting.

Article by
Gemma Jones

7th November 2017

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Transforming healthcare outsourcing. From small beginnings in 1997, Ashfield has grown rapidly into an international healthcare services organisation. By anticipating...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics